We found that LIAS and CDKN2A were significantly upregulated in tumor samples, and FDX1, DLD, DLAT, PDHA1, PDHB, MTF1, and GLS were significantly downregulated in tumor samples (Figure 1A). Here, CDKN2A is linked to neoplasm.